Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostate Stem Cells and Cancer Stem Cells
Jia J. Li, Michael M. Shen
Cold Spring Harbor Perspectives in Medicine (2018) Vol. 9, Iss. 6, pp. a030395-a030395
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
Bo Wu, Xiang Shi, Meixi Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 100
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 58
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 116
Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips
Wangxin Guo, Lin Li, Juan He, et al.
Nature Genetics (2020) Vol. 52, Iss. 9, pp. 908-918
Open Access | Times Cited: 115
Heterotypic cell–cell communication regulates glandular stem cell multipotency
Alessia Centonze, Shuheng Lin, Elisavet Tika, et al.
Nature (2020) Vol. 584, Iss. 7822, pp. 608-613
Open Access | Times Cited: 114
Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development
Hisham F. Bahmad, Mohammad Jalloul, Joseph Azar, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 60
ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 15
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
The FGF/FGFR system in the physiopathology of the prostate gland
Arianna Giacomini, Elisabetta Grillo, Sara Rezzola, et al.
Physiological Reviews (2020) Vol. 101, Iss. 2, pp. 569-610
Closed Access | Times Cited: 58
Drug and apoptosis resistance in cancer stem cells (CSCs): A puzzle with many pieces
Ahmad R. Safa
Cancer Drug Resistance (2022) Vol. 5, Iss. 4, pp. 850-72
Open Access | Times Cited: 34
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
Paolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3879-3896
Closed Access | Times Cited: 6
Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research
Mohamed Elbadawy, Amira Abugomaa, Hideyuki Yamawaki, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 777-777
Open Access | Times Cited: 49
Prostate Cancer Stem Cells: Clinical Aspects and Targeted Therapies
Isis Wolf, Christian Gratzke, Philipp Wolf
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
The lipid rafts in cancer stem cell: a target to eradicate cancer
Shuo Zhang, Neng Zhu, Hong Fang Li, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Cancer Stem Cells and Prostate Cancer: A Narrative Review
Yazan Al Salhi, Manfredi Bruno Sequi, Fabio Maria Valenzi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7746-7746
Open Access | Times Cited: 13
BAZ2A‐mediated repression via H3K14ac‐marked enhancers promotes prostate cancer stem cells
Rodrigo Peña‐Hernández, Rossana Aprigliano, Sandra C. Frommel, et al.
EMBO Reports (2021) Vol. 22, Iss. 11
Open Access | Times Cited: 30
Prostate luminal progenitor cells: from mouse to human, from health to disease
Manon Baurès, Charles Dariane, Elisavet Tika, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 4, pp. 201-218
Open Access | Times Cited: 20
State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer
Saravanan Ramesh, Preethi Selvakumar, Mohamed Yazeer Ameer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Gland- and cell-level heterogeneity in the prostate: A narrative review of related diseases
Gang Wang, Cai Lv, Zhenxiang Liu, et al.
Current Urology (2025)
Open Access
In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma
Udit Basak, Sumon Mukherjee, Sourio Chakraborty, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer
Zezhen Liu, Zhaodong Han, Yingke Liang, et al.
Cellular Signalling (2019) Vol. 59, pp. 152-162
Closed Access | Times Cited: 30
Dynamics of Cellular Plasticity in Prostate Cancer Progression
Ritika Tiwari, Nishat Manzar, Bushra Ateeq
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 28
Reporters of Cancer Stem Cells as a Tool for Drug Discovery
Amrutha Mohan, Reshma Raj R, Gayathri Mohan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
Heterogeneity and complexity of the prostate epithelium: New findings from single-cell RNA sequencing studies
Laura Crowley, Michael M. Shen
Cancer Letters (2021) Vol. 525, pp. 108-114
Open Access | Times Cited: 25
PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
Xiaoli Sheng, Yunxian Li, Yixuan Li, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top